Chronic spontaneous urticaria (CSU) is a debilitating skin disease characterized by
intensely itchy wheals, angioedema, or both. Symptoms recur spontaneously, on a near …

Guidelines for the treatment of chronic spontaneous urticaria (CSU) recommend the use of
the IgE-targeted biologic omalizumab in patients with antihistamine-refractory disease. The …

Background In the majority of patients with chronic spontaneous urticaria, most currently
available therapies do not result in complete symptom control. Ligelizumab is a next …

Chronic spontaneous urticaria (CSU) is defined as the spontaneous development of itchy
hives and/or angioedema due to known or unknown causes that last for at least 6 weeks. At …

Omalizumab is an effective treatment for patients with chronic spontaneous urticaria (CSU).
In routine clinical practice, physicians often face complex cases of CSU and need to decide …

Chronic rhinosinusitis with nasal polyps (CRSwNP) is a complex, clinically heterogeneous
and persistent inflammatory disorder of the upper airway. Detailed mechanistic insights into …

Abstract Purpose of Review Since omalizumab has been approved for urticaria, numerous
randomized and real-life observational trials have been published. We reviewed the period …

Chronic urticaria and angioedema are diseases often managed by Allergy and Immunology
specialists. Recent international guidelines have outlined a stepwise approach to …

Background: Omalizumab is a third-line treatment for chronic spontaneous urticaria (CSU).
Studies investigating the use of higher doses of omalizumab in patients unresponsive to …

Introduction: This study aimed to evaluate factors affecting drug survival and treatment
response in patients with chronic urticaria treated with omalizumab in clinical practice …